Frontiers in endocrinology · 2025
Revealing the genotype-phenotype correlations of congenital hypothyroidism in Yunnan Province, Southwest China.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Yinhong, Wang Shiyu, Li Aoyu, Zhao Wenjing, Xia Fengyu, Chan Ying, Lin Junyue, Zhou Xiaoyan, Li Suyun, Feng Na, Zhu Baosheng, Li Li
Аннотация
CONTEXT: Congenital hypothyroidism (CH) is a congenital endocrine disorder with diverse clinical presentations. The genotype-phenotype relationship has recently become a focal point in genetic etiology research on CH.
OBJECTIVE: To explore the correlation between genetic variants and the clinical and biochemical characteristics of patients with CH in Yunnan Province, Southwest China.
METHODS: A retrospective analysis of 117 Yunnan-origin CH patients was conducted. Target regions capture next-generation sequencing (NGS) was used to screen for variations in all exons and their exon-intron boundaries in 27 CH-related genes. Patients were categorized into groups based on genetic variations; clinical outcomes were assessed through standardized follow-up.
RESULTS: Among the 117 CH patients, 91 carried gene variations related to CH, yielding a detection rate of 77.8%. Notably, variations in DUOX2, DUOXA2, and TG was most prevalent. Specifically, DUOX2 gene variations were found in 67 CH patients; these mutations encompassed 47 variant types, with K530X, R885L, and R1110Q being the most common in the Chinese cohort. CH patients exhibiting goiter and thyroid dysgenesis required a higher initial levothyroxine (L-T4) dose. As the number of gene variants increased, thyroid morphology gradually shifted toward "goiter" and "dysgenesis". No significant differences were observed in biochemical characteristics or clinical outcomes among genetic variant groups.
CONCLUSIONS: This study provides valuable insights into the genetic landscape of CH in Yunnan Province, highlighting the importance of genes associated with thyroid dyshormonogenesis. Genotype cannot effectively be used to predict CH phenotype and prognosis. Standardized treatment and follow-up are crucial for positive outcomes in CH children.
OBJECTIVE: To explore the correlation between genetic variants and the clinical and biochemical characteristics of patients with CH in Yunnan Province, Southwest China.
METHODS: A retrospective analysis of 117 Yunnan-origin CH patients was conducted. Target regions capture next-generation sequencing (NGS) was used to screen for variations in all exons and their exon-intron boundaries in 27 CH-related genes. Patients were categorized into groups based on genetic variations; clinical outcomes were assessed through standardized follow-up.
RESULTS: Among the 117 CH patients, 91 carried gene variations related to CH, yielding a detection rate of 77.8%. Notably, variations in DUOX2, DUOXA2, and TG was most prevalent. Specifically, DUOX2 gene variations were found in 67 CH patients; these mutations encompassed 47 variant types, with K530X, R885L, and R1110Q being the most common in the Chinese cohort. CH patients exhibiting goiter and thyroid dysgenesis required a higher initial levothyroxine (L-T4) dose. As the number of gene variants increased, thyroid morphology gradually shifted toward "goiter" and "dysgenesis". No significant differences were observed in biochemical characteristics or clinical outcomes among genetic variant groups.
CONCLUSIONS: This study provides valuable insights into the genetic landscape of CH in Yunnan Province, highlighting the importance of genes associated with thyroid dyshormonogenesis. Genotype cannot effectively be used to predict CH phenotype and prognosis. Standardized treatment and follow-up are crucial for positive outcomes in CH children.